Injectable antioxidant hyaluronan/chitosan hydrogel as a platelet-rich plasma and stem cell carrier to promote endometrial regeneration and fertility restoration
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This study developed an injectable hyaluronan/chitosan hydrogel loaded with antioxidant properties to serve as a carrier for platelet-rich plasma and stem cells, promoting endometrial regeneration and fertility restoration.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Severe damage to the uterine endometrium can lead to thin endometrium and intrauterine adhesions (IUAs), resulting in infertility or complications during pregnancy. Therapies utilizing mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) represent promising strategies for restoring thin endometrium. However, the low homing rate and functionality of transplanted cells, along with the rapid release of PRP growth factors, limit their therapeutic efficacy. In this study, we developed an in-situ formable and redox-responsive hydrogel composed of thiolated hyaluronan (tHA) and thiolated chitosan (tChi) (tHA-tChi) for encapsulating PRP and mouse adipose-derived stem cells (ADSCs). Our results demonstrate that the tHA-tChi hydrogel exhibits appropriate swelling, injectability, self-healing, and antioxidant properties, alongside a sustained release of PRP growth factors. In vitro experiments indicated that the PRP and ADSCs encapsulated within the hydrogel (ADSCs/tHA-tChi/PRP) stimulated angiogenesis in endothelial cells. In a mouse model of thin endometrium, the ADSCs/tHA-tChi/PRP significantly enhanced endometrial regeneration, as evidenced by increased endometrial thickness and reduced fibrosis. This improvement markedly enhanced endometrial receptivity and pregnancy rates in damaged endometria, correlating with increased angiogenesis and endometrial cell proliferation via activation of the VEGF/AKT/BAD pathway, as shown by Western blotting assays. Overall, the combination of antioxidant hydrogel, PRP, and ADSCs demonstrates promising potential for promoting endometrial regeneration and restoring fertility, offering new minimally invasive therapeutic options for endometrial diseases. STATEMENT OF SIGNIFICANCE: This research presents a potent approach to the treatment of thin endometrium, employing an injectable, biodegradable and antioxidant hydrogel comprising thiolated hyaluronic acid (tHA) and thiolated chitosan (tChi). The antioxidant capacity of the hydrogel improves the oxidative microenvironment of the injured uterus, while the hydrogel is designed to release adipose-derived stem cells (ADSCs) and growth factors from platelet-rich plasma (PRP) sustainably, promoting tissue regeneration by enhancing angiogenesis and endometrium cell proliferation. Demonstrated efficacy in a mouse model of thin endometrium indicates its great potential to significantly improve fertility restoration treatments. The administration of antioxidant hydrogel containing ADSCs and PRP represents a promising therapeutic strategy for patients with endometrial disease.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Reconstructable Uterus‐Derived Materials for Uterus Recovery toward Efficient Live Births 2021
- The Importance of Natural Antioxidants in Female Reproduction 2023
- Locationally activated PRP via an injectable dual-network hydrogel for endometrial regeneration 2024
- Recent Developments in Biomaterial-Based Hydrogel as the Delivery System for Repairing Endometrial Injury 2022
Cited by (4)
- Obesity and oxidative stress: potential mechanisms in endometrial disorders 2026
- Uterine Drug-Delivery Systems 2026
- Regenerating the uterus: translational advances in endometrial bioengineering and immunotherapeutics 2025
- Natural regeneration-inspired sequential delivery of synergistic growth factors for structural and functional endometrial regeneration 2025
References (45)
- Locationally activated PRP via an injectable dual-network hydrogel for endometrial regeneration via openalex
- Recent Developments in Biomaterial-Based Hydrogel as the Delivery System for Repairing Endometrial Injury via openalex
- Reconstructable Uterus‐Derived Materials for Uterus Recovery toward Efficient Live Births via openalex
- The Importance of Natural Antioxidants in Female Reproduction via openalex
- W2486397717 via openalex
- W2746597344 via openalex
- W2788841968 via openalex
- W2792410134 via openalex
- W2793029785 via openalex
- W2810138759 via openalex
- W2890819900 via openalex
- W2903164786 via openalex
- W2920123672 via openalex
- W2922280011 via openalex
- W2927173694 via openalex
- W2966063711 via openalex
- W2968429189 via openalex
- W3021081539 via openalex
- W3036862622 via openalex
- W3080458589 via openalex
- W3080682099 via openalex
- W3085318222 via openalex
- W3110285732 via openalex
- W3127698120 via openalex
- W3128272978 via openalex
- W3139188823 via openalex
- W3139498438 via openalex
- W4210312610 via openalex
- W4210676133 via openalex
- W4220722119 via openalex
- W4221003104 via openalex
- W4229035951 via openalex
- W4280544323 via openalex
- W4297184096 via openalex
- W4306725820 via openalex
- W4321766507 via openalex
- W4391785128 via openalex
- W4391941130 via openalex
- W4400225139 via openalex
- W4402762393 via openalex
- doi:10.29328/journal.jsctt.1001013 via openalex
- W6872981196 via openalex
- W1985478624 via openalex
- W2123460271 via openalex
- W2164576139 via openalex
Cited by (4)
- Obesity and oxidative stress: potential mechanisms in endometrial disorders 2026
- Uterine Drug-Delivery Systems 2026
- Regenerating the uterus: translational advances in endometrial bioengineering and immunotherapeutics 2025
- Natural regeneration-inspired sequential delivery of synergistic growth factors for structural and functional endometrial regeneration 2025
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK